Stina Singel

Chief Tech/Sci/R&D Officer presso ASCENDIS PHARMA A/S

Patrimonio netto: 412 543 $ in data 31/03/2024

50 anni

Health Technology

Consumer Services

Posizioni attive di Stina Singel

Società	Posizione	Inizio	Fine
ASCENDIS PHARMA A/S	Chief Tech/Sci/R&D Officer	01/05/2020	-

Società	Posizione	Inizio	Fine
NEKTAR THERAPEUTICS	Corporate Officer/Principal	01/04/2019	01/05/2020
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	01/03/2014	01/04/2019

The Salk Institute for Biological Studies	Doctorate Degree
Harvard University	Undergraduate Degree
University of California San Diego	Doctorate Degree

Distribuzione geografica

Stati Uniti	6
Danimarca	2

Posizioni

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	2
Corporate Officer/Principal	1

Settori

Health Technology	4
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
NEKTAR THERAPEUTICS	Health Technology
ASCENDIS PHARMA A/S	Health Technology

Aziende private	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology

Aziende private

Health Technology